Zacks Investment Research lowered shares of MDXHealth SA (NASDAQ:MXDHF) from a buy rating to a hold rating in a research report report published on Saturday.

According to Zacks, “MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company’s tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. “

MDXHealth SA (NASDAQ MXDHF) remained flat at $5.90 on Friday. The stock’s 50-day moving average is $5.75 and its 200 day moving average is $5.67. The stock’s market cap is $294.70 million. MDXHealth SA has a one year low of $3.80 and a one year high of $6.15.

TRADEMARK VIOLATION NOTICE: “MDXHealth SA (MXDHF) Downgraded to “Hold” at Zacks Investment Research” was first posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/09/17/mdxhealth-sa-mxdhf-downgraded-to-hold-at-zacks-investment-research.html.

Receive News & Ratings for MDXHealth SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDXHealth SA and related companies with MarketBeat.com's FREE daily email newsletter.